Authors:
Ando, M
Tamayose, K
Sugimoto, K
Oshimi, K
Citation: M. Ando et al., Secondary myelodysplastic syndrome after treatment of prostate cancer withoral estramustine, AM J HEMAT, 67(4), 2001, pp. 274-275
Authors:
Mochizuki, H
Hayakawa, H
Migita, M
Shibata, M
Tanaka, R
Suzuki, A
Shimo-Nakanishi, Y
Urabe, T
Yamada, M
Tamayose, K
Shimada, T
Miura, M
Mizuno, Y
Citation: H. Mochizuki et al., An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease, P NAS US, 98(19), 2001, pp. 10918-10923
Authors:
Tamayose, K
Sugimoto, K
Ando, M
Oshimi, K
Citation: K. Tamayose et al., Disappearance of chromosomal abnormalities and recovery of hematopoiesis after immunosuppressive therapy for hypoplastic refractory anemia with excess of blasts, BLOOD, 97(8), 2001, pp. 2524-2524
Citation: W. Satoh et al., Site-specific integration of an adeno-associated virus vector plasmid mediated by regulated expression of rep based on Cre-loxP recombination, J VIROLOGY, 74(22), 2000, pp. 10631-10638
Authors:
Sugimoto, K
Tamayose, K
Takagi, M
Yamada, K
Sasaki, M
Mizutani, S
Oshimi, K
Citation: K. Sugimoto et al., Activation of an ataxia telangiectasia mutation-dependent intra-S-phase checkpoint by anti-tumour drugs in HL-60 and human lymphoblastoid cells, BR J HAEM, 110(4), 2000, pp. 819-825
Authors:
Sugimoto, K
Sasaki, M
Tamayose, K
Oshimi, K
Citation: K. Sugimoto et al., Inhibition of p34(cdc2) dephosphorylation in DNA damage- and topoisomeraseII inactivation-induced G2 arrests in HL-60 cells, BR J HAEM, 105(3), 1999, pp. 720-729